ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
동물용 의약품 조제 시장의 규모는 최근 현저한 성장을 보이고 있습니다. 2025년 17억 9,000만 달러에서 2026년에는 19억 1,000만 달러로, CAGR 7.0%로 확대할 전망입니다. 지난 수년간의 성장세는 반려동물의 만성질환 증가, 동물병원 진료 건수 증가, 유연한 제형에 대한 수요, 반려동물 수 증가, 동물용의약품 기업 확대 등이 주요 요인으로 꼽힙니다.
동물용 의약품 조제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 25억 8,000만 달러에 달하며, CAGR은 7.8%에 달할 전망입니다. 예측 기간의 성장 요인으로는 조제 기술의 발전, 맞춤형 의료에서의 AI 도입 증가, 가축 치료 용도 확대, 맞춤형 수의학에 대한 인식 개선, 수의 진단과의 통합 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 개인 맞춤형 동물용 의약품에 대한 수요 증가, 주사제 및 경구용 의약품의 확대, 반려동물 건강에 대한 관심 증가, 수의 진단 및 조제 기술의 통합, 맞춤형 호르몬 요법 및 항염증 요법의 도입 등이 있습니다.
반려동물 관련 지출 증가는 동물용 의약품 조제 시장의 성장을 가속할 것으로 예측됩니다. 반려동물 관련 지출은 반려동물의 양육 및 관리와 관련된 다양한 측면에 대한 총 지출을 의미합니다. 이러한 지출은 개별 동물의 고유한 요구를 충족시키는 맞춤형 의약품에 대한 수요에 기여하고, 조제 약국이 수의학 분야에서 이러한 전문 서비스를 계속 제공하도록 장려하고 있습니다. 예를 들어 2023년 10월 미국 반려동물 건강보험협회(NAPHIA)는 2022년 미국 반려동물 보호자들이 개, 고양이, 새, 기타 반려동물에 지출한 금액이 1,368억 달러에 달했으며, 이 수치는 2023년 1,436억 달러로 증가할 것이라고 발표했습니다. 증가할 것으로 예측된다고 발표했습니다. 따라서 반려동물 관련 지출 증가가 동물용의약품 조제 시장의 성장을 촉진하고 있습니다.
동물용 의약품 제제 시장의 주요 기업은 고양이 전용 의약품의 안전성과 효능을 향상시키기 위해 고양이 친화적인 제제 등 혁신적인 제품을 개발하고 있습니다. 고양이 친화적 제제는 고양이에게 안전하고 효과적이며 고양이가 선호하도록 조정된 제품입니다. 예를 들어 2024년 9월 미국 소재 수의약품 기업 웨지우드(Wedgewood)는 조제형 몰누피라비르를 출시했습니다. 이 항바이러스제는 고양이 전염성 복막염(FIP) 치료를 위해 특별히 제조된 항바이러스제입니다. 웨지우드사는 삼출성, 비삼출성, 신경형, 안구형 등 다양한 형태의 FIP에 대응하기 위해 다양한 용량의 고양이 친화적인 몰누피라빌을 제공합니다. 여기에는 고양이 환자 개개인의 고유한 요구를 충족시키기 위해 향이 첨가된 경구용 오일 현탁액과 캡슐 등 다양한 용량과 맛의 제품이 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Animal drug compounding involves the process of customizing and altering the ingredients of multiple medicines to create a personalized medication suitable for the specific needs of individual animals or groups of animals. This practice is crucial in veterinary medicine for providing tailored medical treatment to animals.
The primary products of animal drug compounding include anti-infective agents, anti-inflammatory agents, hormones and substitutes, central nervous system (CNS) agents, and other specialized products. Anti-infective agents encompass medications such as antibiotics, antivirals, and antifungals, used to prevent and treat various infections in animals. These agents play a vital role in eliminating infectious germs and controlling the spread of infections among animals. Animal drug compounding is applicable to various types of animals, including companion animals and livestock, and can be administered through different routes such as oral, injectable, topical, among others. This practice is commonly employed in veterinary hospitals, clinics, and diagnostic centers dedicated to veterinary care.
Tariffs have impacted the animal drug compounding market by raising the cost of imported active pharmaceutical ingredients, excipients, and specialized compounding equipment, affecting veterinary hospitals and clinics budgets. Companion animal medications in North America and Europe, and livestock treatment products in Asia-Pacific, are most affected due to dependence on imported high-quality ingredients. Positively, tariffs are promoting local production, encouraging innovation in cost-effective compounding solutions, and strengthening regional supply chains to reduce import reliance.
The animal drug compounding market research report is one of a series of new reports from The Business Research Company that provides animal drug compounding market statistics, including animal drug compounding industry global market size, regional shares, competitors with a animal drug compounding market share, detailed animal drug compounding market segments, market trends and opportunities, and any further data you may need to thrive in the animal drug compounding industry. This animal drug compounding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The animal drug compounding market size has grown strongly in recent years. It will grow from $1.79 billion in 2025 to $1.91 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to rising prevalence of chronic diseases in companion animals, increasing veterinary clinic visits, demand for flexible dosage forms, growth of companion animal population, expansion of veterinary pharmaceutical companies.
The animal drug compounding market size is expected to see strong growth in the next few years. It will grow to $2.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to advancements in drug compounding technologies, increasing adoption of AI for personalized medicine, growth in livestock treatment applications, rising awareness of customized veterinary therapies, expansion of veterinary diagnostic integration. Major trends in the forecast period include growing demand for personalized veterinary medications, expansion of injectable and oral compounded drugs, increasing focus on companion animal health, integration of veterinary diagnostics with drug compounding, adoption of customized hormonal and anti-inflammatory therapies.
Increasing pet expenditure is expected to further propel the growth of the animal drug compounding market. Pet expenditure encompasses the total amount spent on various aspects of pet ownership and care. This spending contributes to the demand for tailored medications that address the unique needs of individual animals, thereby encouraging compounding pharmacies to continue offering these specialized services in veterinary care. For instance, in October 2023, the North American Pet Health Insurance Association (NAPHIA), a US-based trade organization, stated that in 2022, pet owners in the United States spent $136.8 billion on their dogs, cats, birds, and other companion animals, with this figure projected to increase to $143.6 billion in 2023. Therefore, the rising pet expenditure is driving the growth of the animal drug compounding market.
Major companies in the animal drug compounding market are creating innovative products, such as feline-friendly formulations, to improve the safety and effectiveness of medications specifically designed for cats. Feline-friendly formulations are products tailored to be safe, effective, and appealing to cats. For instance, in September 2024, Wedgewood, a US-based veterinary pharmaceutical company, launched compounded molnupiravir. This antiviral medication is specifically formulated to treat Feline Infectious Peritonitis (FIP) in cats. Wedgewood offers various dosages of feline-friendly molnupiravir to address different forms of FIP, including effusive, non-effusive, neurological, and ocular types. This includes producing a range of dosages and flavors, such as flavored oral oil suspensions and capsules, to cater to the unique needs of individual feline patients.
In May 2024, MixLab, a US-based pharmaceutical laboratory, acquired Nexgen Animal Health for an undisclosed amount. This acquisition aims to expand MixLab's veterinary compounding services to include large animals while enhancing the pharmacy experience through advanced technology and increased capacity. Nexgen Animal Health, also based in the US, specializes in formulating innovative products and drug compounds for animals.
Major companies operating in the animal drug compounding market are Akina Animal Health, Letco Medical LLC, The Pet Apothecary LLC, Vetsource Inc., BCP Veterinary Pharmacy, VetRxDirect LLC, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetRx2Go, PetMed Express Inc., Diamondback Drugs, Brava Veterinary Pharmacy, Veterinary Pharmacies of America, MEDS Canadian Compounding Pharmacy, Chiron Compounding Pharmacy, Dougherty's Pharmacy, Pace Pharmacy, Aurora Compounding, ESSENTIAL PHARMACY COMPOUNDING VET, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd, ScriptWorks, Veterinary Specialty Pharmacy, Veterinary Pharmaceutical Solutions, Wedgewood Pharmacy LLC, Hoye's Pharmacy, Triangle Compounding Pharmacy Inc., Vertisis Custom Pharmacy LLC
North America was the largest region in the animal drug compounding market in 2025. The regions covered in the animal drug compounding market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the animal drug compounding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The animal drug compounding market consists of sales of flavored medications, suppositories, and ophthalmic preparations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Animal Drug Compounding Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses animal drug compounding market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for animal drug compounding ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal drug compounding market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Animal Type: Companion Animals; Livestock Animals
2) By Product: Anti-Infective Agents; Anti-inflammatory Agents; Hormones And Substitutes; CNS Agents; Other Products
3) By Route Of Administration: Oral; Injectable; Topical; Other Routes Of Administrations
4) By Application: Veterinary Hospitals; Veterinary Clinics; Veterinary Diagnostic Centers
Subsegments:
1) By Companion Animals: Dogs; Cats; Horses
2) By Livestock Animals: Cattle; Swine; Poultry; Sheep; Goats
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Growing Demand For Personalized Veterinary Medications
4.2.2 Expansion Of Injectable And Oral Compounded Drugs
4.2.3 Increasing Focus On Companion Animal Health
4.2.4 Integration Of Veterinary Diagnostics With Drug Compounding
4.2.5 Adoption Of Customized Hormonal And Anti-Inflammatory Therapies
5. Animal Drug Compounding Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Veterinary Clinics
5.3 Veterinary Diagnostic Centers
5.4 Livestock Farms
5.5 Pet Owners
6. Animal Drug Compounding Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Animal Drug Compounding Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Animal Drug Compounding PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Animal Drug Compounding Market Size, Comparisons And Growth Rate Analysis
7.3. Global Animal Drug Compounding Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Animal Drug Compounding Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Animal Drug Compounding Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Animal Drug Compounding Market Segmentation
9.1. Global Animal Drug Compounding Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Companion Animals, Livestock Animals
9.2. Global Animal Drug Compounding Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Anti-Infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products
9.3. Global Animal Drug Compounding Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Injectable, Topical, Other Routes Of Administrations
9.4. Global Animal Drug Compounding Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Animal Drug Compounding Market, Sub-Segmentation Of Companion Animals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Dogs, Cats, Horses
9.6. Global Animal Drug Compounding Market, Sub-Segmentation Of Livestock Animals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cattle, Swine, Poultry, Sheep, Goats
10. Animal Drug Compounding Market Regional And Country Analysis
10.1. Global Animal Drug Compounding Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Animal Drug Compounding Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Animal Drug Compounding Market
11.1. Asia-Pacific Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Animal Drug Compounding Market
12.1. China Animal Drug Compounding Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Animal Drug Compounding Market
13.1. India Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Animal Drug Compounding Market
14.1. Japan Animal Drug Compounding Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Animal Drug Compounding Market
15.1. Australia Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Animal Drug Compounding Market
16.1. Indonesia Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Animal Drug Compounding Market
17.1. South Korea Animal Drug Compounding Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Animal Drug Compounding Market
18.1. Taiwan Animal Drug Compounding Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Animal Drug Compounding Market
19.1. South East Asia Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Animal Drug Compounding Market
20.1. Western Europe Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Animal Drug Compounding Market
21.1. UK Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Animal Drug Compounding Market
22.1. Germany Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Animal Drug Compounding Market
23.1. France Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Animal Drug Compounding Market
24.1. Italy Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Animal Drug Compounding Market
25.1. Spain Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Animal Drug Compounding Market
26.1. Eastern Europe Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Animal Drug Compounding Market
27.1. Russia Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Animal Drug Compounding Market
28.1. North America Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Animal Drug Compounding Market
29.1. USA Animal Drug Compounding Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Animal Drug Compounding Market
30.1. Canada Animal Drug Compounding Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Animal Drug Compounding Market
31.1. South America Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Animal Drug Compounding Market
32.1. Brazil Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Animal Drug Compounding Market
33.1. Middle East Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Animal Drug Compounding Market
34.1. Africa Animal Drug Compounding Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Animal Drug Compounding Market, Segmentation By Animal Type, Segmentation By Product, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Animal Drug Compounding Market Regulatory and Investment Landscape
36. Animal Drug Compounding Market Competitive Landscape And Company Profiles
36.1. Animal Drug Compounding Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Animal Drug Compounding Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Animal Drug Compounding Market Company Profiles
36.3.1. Akina Animal Health Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Letco Medical LLC Overview, Products and Services, Strategy and Financial Analysis
36.3.3. The Pet Apothecary LLC Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Vetsource Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. BCP Veterinary Pharmacy Overview, Products and Services, Strategy and Financial Analysis
37. Animal Drug Compounding Market Other Major And Innovative Companies
VetRxDirect LLC, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetRx2Go, PetMed Express Inc., Diamondback Drugs, Brava Veterinary Pharmacy, Veterinary Pharmacies of America, MEDS Canadian Compounding Pharmacy, Chiron Compounding Pharmacy, Dougherty's Pharmacy, Pace Pharmacy, Aurora Compounding, ESSENTIAL PHARMACY COMPOUNDING VET, SCIRx Pharmacy
38. Global Animal Drug Compounding Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Animal Drug Compounding Market
40. Animal Drug Compounding Market High Potential Countries, Segments and Strategies
40.1 Animal Drug Compounding Market In 2030 - Countries Offering Most New Opportunities
40.2 Animal Drug Compounding Market In 2030 - Segments Offering Most New Opportunities
40.3 Animal Drug Compounding Market In 2030 - Growth Strategies
